share_log

B of A Securities Upgrades Sabra Health Care REIT to Neutral, Raises Price Target to $14

B of A Securities Upgrades Sabra Health Care REIT to Neutral, Raises Price Target to $14

B of A Securities將Sabra Health Care REIT上調至中性,將目標股價上調至14美元
Benzinga ·  2023/08/11 09:15

B of A Securities analyst Joshua Dennerlein upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Neutral and raises the price target from $11 to $14.

美國銀行證券分析師Joshua Dennerlein將Sabra Health Care REIT(納斯達克:SBRA)從表現不佳上調至中性,並將目標價從11美元上調至14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論